Radovancevic B, Poindexter S, Birovljev S, Velebit V, McAllister H A, Duncan J M, Vega D, Lonquist J, Burnett C M, Frazier O H
Cullen Cardiovascular Surgical Research Laboratory, Texas Heart Institute, Houston.
Eur J Cardiothorac Surg. 1990;4(6):309-12; discussion 313. doi: 10.1016/1010-7940(90)90207-g.
Allograft coronary artery disease (CAD) is the major determinant of long-term survival following heart transplantation (HTx). In a group of 210 heart transplant recipients, we diagnosed CAD in 54 (27.1%) by coronary angiography, postmortem examination or examination of the transplanted heart at the time of retransplantation. Retrospective analysis of potential risk factors for the development of CAD was performed for both immunological (rejection pattern, immunosuppressive therapy, cytomegalovirus [CMV] infection), and nonimmunological (hyperlipidemia, smoking, hypertension, diabetes mellitus, obesity) risk factors. The total number of rejection episodes correlated significantly with the occurrence of CAD (P less than 0.05), showing that patients who experienced two or more rejection episodes had an incidence of CAD of 40%, as opposed to a 23% incidence in patients who experienced no rejection. A composite rejection score derived from multivariate regression analysis of the severity, frequency, and timing of acute cardiac rejection episodes was found to correlate with the development of CAD (P less than 0.05). Postoperative arterial hypertension also correlated significantly with the onset of CAD (P less than 0.01), with a 92.6% incidence of hypertension in the group with CAD versus 76.3% in the group without CAD. Smoking after transplantation correlated significantly with the occurrence of CAD (P less than 0.05). There was no significant correlation with other analyzed factors in this group of patients. In this review, the development of CAD after heart transplantation correlated with treated allograft rejection. Aggressive treatment of hypertension and cessation of smoking may contribute to alleviation of this serious complication.
同种异体移植冠状动脉疾病(CAD)是心脏移植(HTx)后长期生存的主要决定因素。在一组210例心脏移植受者中,我们通过冠状动脉造影、尸检或再次移植时对移植心脏的检查,在54例(27.1%)患者中诊断出CAD。我们对免疫(排斥模式、免疫抑制治疗、巨细胞病毒[CMV]感染)和非免疫(高脂血症、吸烟、高血压、糖尿病、肥胖)危险因素进行了回顾性分析,以探讨CAD发生的潜在危险因素。排斥发作的总数与CAD的发生显著相关(P<0.05),表明经历两次或更多次排斥发作的患者CAD发生率为40%,而未经历排斥发作的患者CAD发生率为23%。通过对急性心脏排斥发作的严重程度、频率和时间进行多变量回归分析得出的综合排斥评分与CAD的发生相关(P<0.05)。术后动脉高血压也与CAD的发生显著相关(P<0.01),CAD组高血压发生率为92.6%,无CAD组为76.3%。移植后吸烟与CAD的发生显著相关(P<0.05)。在这组患者中,与其他分析因素无显著相关性。在本综述中,心脏移植后CAD的发生与移植心脏排斥反应的治疗情况相关。积极治疗高血压和戒烟可能有助于缓解这一严重并发症。